Fate Therapeutics, Inc.

Return to Grants

Total Awards:
Award Value:
Institution type:
For profit
Short Name:
Fate Therapeutics

Awards to the Institution

Program Type Investigator Grant Title Award Value
Clinical Trial Stage Projects Barbara Hickingbottom A Phase 1 Study of FT819 in Participants with Moderate to Severe Active Systemic Lupus Erythematosus $7,934,448
Late Stage Preclinical Projects Dr Bob Valamehr IND enabling development of FT516: A Natural Killer Cell Immunotherapy for Cancer Derived from a Human Inducible Pluripotent Stem Cell $4,000,000